Bavarian Nordic A/S - Special Call Transcript
Ladies and gentlemen, thank you for standing by and welcome to the Bavarian Nordic Q&A session. (Operator Instructions) Please be advised that this conference is being recorded. (Operator Instructions)
I'd now like to hand the conference over to your speaker today, Mr. Rolf Sass, CEO (sic) [Vice President, Investor Relations].
¸ - /-&
Thank you, and welcome to this conference regarding Bavarian Nordic's acquisition of 2 commercial vaccines from GSK. With me, I have our Chief Financial Officer, Henrik Juuel; as well as our President and CEO, Paul Chaplin.
Before we start, I need to read the forward-looking statements. This presentation includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside our control, that could cause actual results to differ materially from the results discussed.
Forward-looking statements include statements regarding our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

